| (210) | Number of the EPO application | 17787774 |
| (220) | Filing date of the EPO application | 2017.10.05 |
| (80) | EPO patent specification publication (B) | EPB nr. 23/2021, 2021.06.09 |
| (110) | EPO patent number | 3523283 |
| (21) | Number of the application | e 2019 0904 |
| (71) | Name(s) of applicant(s), code of the country | MITOBRIDGE, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | LAGU Bharat, US;
TRZASKA Scott, US; |
| (73) | Name(s) of owner(s), code of the country | MITOBRIDGE INC., US; |
| (54) | Title of the invention | CRYSTALLINE AND SALT FORMS OF PPAR AGONIST COMPOUNDS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 233/64 (2006.01.01); C07D 401/04 (2006.01.01); A61K 31/4174 (2006.01.01); A61K 31/4439 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.09.30 |
| (30) | Priority | 201662404474 P, 2016.10.05, US |
| (86) | International application | PCT/US2017/055403, 2017.10.05 |
| (87) | International publication | WO 2018/067860, 2018.04.12 |